NO20040611L - Ekspanderbar gastrisk retensjonsanordning. - Google Patents
Ekspanderbar gastrisk retensjonsanordning.Info
- Publication number
- NO20040611L NO20040611L NO20040611A NO20040611A NO20040611L NO 20040611 L NO20040611 L NO 20040611L NO 20040611 A NO20040611 A NO 20040611A NO 20040611 A NO20040611 A NO 20040611A NO 20040611 L NO20040611 L NO 20040611L
- Authority
- NO
- Norway
- Prior art keywords
- retention device
- gastric retention
- expandable gastric
- materials
- expandable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
- A61K49/0414—Particles, beads, capsules or spheres
- A61K49/0419—Microparticles, microbeads, microcapsules, microspheres, i.e. having a size or diameter higher or equal to 1 micrometer
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Jellies, Jams, And Syrups (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31307801P | 2001-08-16 | 2001-08-16 | |
| PCT/US2001/046146 WO2003015745A1 (en) | 2001-08-16 | 2001-10-22 | Expandable gastric retention device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20040611L true NO20040611L (no) | 2004-04-16 |
Family
ID=23214285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20040611A NO20040611L (no) | 2001-08-16 | 2004-02-11 | Ekspanderbar gastrisk retensjonsanordning. |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1416914A1 (es) |
| JP (1) | JP2005501097A (es) |
| KR (1) | KR20040032918A (es) |
| CN (1) | CN1543337A (es) |
| BR (1) | BR0117123A (es) |
| CA (1) | CA2456976A1 (es) |
| CO (1) | CO5670360A2 (es) |
| IL (1) | IL160363A0 (es) |
| MX (1) | MXPA04001388A (es) |
| NO (1) | NO20040611L (es) |
| NZ (1) | NZ531461A (es) |
| PL (1) | PL368327A1 (es) |
| WO (1) | WO2003015745A1 (es) |
| ZA (1) | ZA200402066B (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7427391B2 (en) * | 2001-11-21 | 2008-09-23 | E-Z-Em, Inc. | Formulations for use in medical and diagnostic procedures |
| WO2005062898A2 (en) * | 2003-12-24 | 2005-07-14 | Advancis Pharmaceutical Corporation | Enhanced absorption of modified release dosage forms |
| US7699863B2 (en) | 2005-03-01 | 2010-04-20 | Tulip Medical Ltd. | Bioerodible self-deployable intragastric implants |
| US7785291B2 (en) | 2005-03-01 | 2010-08-31 | Tulip Medical Ltd. | Bioerodible self-deployable intragastric implants |
| EP2046397A2 (en) * | 2006-07-19 | 2009-04-15 | SmithKline Beecham Corporation | Method for radiolabeling formulations for gamma scintigraphy assesment |
| CN102552103B (zh) * | 2010-12-20 | 2013-11-20 | 西安力邦医药科技有限责任公司 | 拉米夫定固体分散体、其制备方法、药物组合物和用途 |
| CN104334123B (zh) | 2012-06-07 | 2019-02-12 | 意比图密医疗有限公司 | 膨胀装置 |
| WO2015083171A1 (en) | 2013-12-05 | 2015-06-11 | Tulip Medical Ltd. | Retentive devices and systems for in-situ release of pharmaceutical active agents |
| ES2832334T3 (es) | 2014-06-11 | 2021-06-10 | Massachusetts Inst Technology | Estructuras de permanencia y métodos relacionados |
| US20170266112A1 (en) | 2014-06-11 | 2017-09-21 | Massachusetts Institute Of Technology | Residence structures and related methods |
| EP3288604B1 (en) | 2015-05-01 | 2021-11-17 | Massachusetts Institute of Technology | Triggerable shape memory induction devices |
| WO2017070612A1 (en) | 2015-10-23 | 2017-04-27 | Lyndra, Inc. | Gastric residence systems for sustained release of therapeutic agents and methods of use thereof |
| KR20180090881A (ko) | 2015-12-08 | 2018-08-13 | 린드라 인코퍼레이티드 | 위 체류 시스템을 위한 기하 구성형태 |
| CA3038557A1 (en) | 2016-09-30 | 2018-04-05 | Lyndra, Inc. | Gastric residence systems for sustained delivery of adamantane-class drugs |
| WO2019126218A1 (en) * | 2017-12-18 | 2019-06-27 | Tris Pharma, Inc. | Modified release drug powder composition comprising gastro-retentive raft forming systems having trigger pulse drug release |
| TR201914116A2 (tr) * | 2019-09-17 | 2021-04-21 | Univ Yeditepe | Doğal bi̇yomateryaller i̇le kri̇yojelleri̇n üreti̇m yöntemi̇ ve bu kri̇yojelleri̇n yumuşak doku i̇skelesi̇ veya i̇laç taşiyici si̇stem olarak kullanimi |
| WO2022195476A1 (en) | 2021-03-15 | 2022-09-22 | Clexio Biosciences Ltd. | Gastroretentive devices for assessment of intragastric conditions |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4764380A (en) * | 1982-03-22 | 1988-08-16 | Alza Corporation | Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills |
| US5232704A (en) * | 1990-12-19 | 1993-08-03 | G. D. Searle & Co. | Sustained release, bilayer buoyant dosage form |
| DE4406424A1 (de) * | 1994-02-28 | 1995-08-31 | Bayer Ag | Expandierbare Arzneiformen |
| EP1003476B1 (en) * | 1997-08-11 | 2004-12-22 | ALZA Corporation | Prolonged release active agent dosage form adapted for gastric retention |
| NZ510487A (en) * | 1998-09-14 | 2003-04-29 | Ranbaxy Lab Ltd | Pharmaceutical composition comprising ciprofloxacin, sodium alginate, xanthan gum and a cross-linker polymer in a tablet or capsule form |
| JP2000256216A (ja) * | 1999-03-04 | 2000-09-19 | Meiji Milk Prod Co Ltd | ゲル組成物 |
| AU2001268722B8 (en) * | 2000-06-23 | 2005-09-29 | Teva Pharmaceutical Industries Ltd. | Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition |
-
2001
- 2001-10-22 BR BR0117123-2A patent/BR0117123A/pt not_active IP Right Cessation
- 2001-10-22 JP JP2003520705A patent/JP2005501097A/ja not_active Withdrawn
- 2001-10-22 WO PCT/US2001/046146 patent/WO2003015745A1/en active Application Filing
- 2001-10-22 NZ NZ531461A patent/NZ531461A/en unknown
- 2001-10-22 PL PL01368327A patent/PL368327A1/xx not_active Application Discontinuation
- 2001-10-22 CA CA002456976A patent/CA2456976A1/en not_active Abandoned
- 2001-10-22 IL IL16036301A patent/IL160363A0/xx unknown
- 2001-10-22 CN CNA018235441A patent/CN1543337A/zh active Pending
- 2001-10-22 MX MXPA04001388A patent/MXPA04001388A/es not_active Application Discontinuation
- 2001-10-22 EP EP01995328A patent/EP1416914A1/en not_active Withdrawn
- 2001-10-22 KR KR10-2004-7002254A patent/KR20040032918A/ko not_active Application Discontinuation
-
2004
- 2004-02-11 NO NO20040611A patent/NO20040611L/no not_active Application Discontinuation
- 2004-03-12 CO CO04023075A patent/CO5670360A2/es not_active Application Discontinuation
- 2004-03-15 ZA ZA200402066A patent/ZA200402066B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200402066B (en) | 2005-05-09 |
| MXPA04001388A (es) | 2004-05-27 |
| PL368327A1 (en) | 2005-03-21 |
| CA2456976A1 (en) | 2003-02-27 |
| CN1543337A (zh) | 2004-11-03 |
| NZ531461A (en) | 2008-03-28 |
| EP1416914A1 (en) | 2004-05-12 |
| WO2003015745A1 (en) | 2003-02-27 |
| CO5670360A2 (es) | 2006-08-31 |
| KR20040032918A (ko) | 2004-04-17 |
| BR0117123A (pt) | 2004-09-28 |
| IL160363A0 (en) | 2004-07-25 |
| JP2005501097A (ja) | 2005-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20040611L (no) | Ekspanderbar gastrisk retensjonsanordning. | |
| CY1116693T1 (el) | Συνδυασμος αζελαστινης και κυκλεσονιδης | |
| NO20053224D0 (no) | Patient controlled drug administration device. | |
| IS7076A (is) | Bólusetning með einföldum skammti af Mycoplasma hyopneumoniae, og notkun efnisins í lækningaskyni | |
| DE60111908D1 (de) | Implantierbares medizinisches Gerät | |
| BR0110624B1 (pt) | dispositivo fixador anular. | |
| DE60211896D1 (de) | Verformbare langgestreckte medizinische vorrichtung | |
| DE60133702D1 (de) | Medizinisches Stativgerät | |
| DE60109904D1 (de) | Medizinisches zuführungsgerät | |
| NO20041516L (no) | Treningsinnretning. | |
| NO20052855D0 (no) | Fosfonoksykinazolinderivater og farmasoytisk anvendelse derav. | |
| NO20043702L (no) | 8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel | |
| ATE337817T1 (de) | Medizinisches gerät | |
| NO20025580L (no) | Medisinsk anordning | |
| ATE359034T1 (de) | Steuerbare schlaufenstruktur | |
| ITTO20010005A0 (it) | Formulazione farmaceutica. | |
| DE60327090D1 (de) | Implantierbare medizinische vorrichtung | |
| BR0311672B1 (pt) | aparelho de proteção de agulha médica. | |
| DE60108524D1 (de) | Röntgendichte chirurgische vorrichtung | |
| DE60129431D1 (de) | Medizinische vorrichtung | |
| DE60327103D1 (de) | Darreichungsformen enthaltend einen protonpumphemmer, einen nsaid und einen puffer | |
| DK1498411T3 (da) | Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel | |
| ITBO20000453A0 (it) | Apparecchiatura e procedimento per la sterilizzazione del terreno . | |
| DE60115466D1 (de) | Wirkstoffvorläufer von imidazopyridin-derivaten | |
| ATE417856T1 (de) | Motilidverbindungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |